Join to view full profile
1500 Wallace BlvdAmarillo, TX 79106
Phone+1 806-212-4673
Fax+1 806-352-8890
Dr. Pruitt is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1977 - 1980- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1972 - 1975
University of Texas Medical Branch School of MedicineClass of 1972
Certifications & Licensure
TX State Medical License 1981 - 2023
WI State Medical License 1973 - 2019
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013-2014
- Super Doctor SuperDoctors.com
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Dec 10
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Feb 28
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Publications & Presentations
PubMed
- 49 citationsMaintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia.Seah H. Lim, Yana Zhang, Zhiqing Wang, William V. Esler, David Beggs
Bone Marrow Transplantation. 2005-01-01 - 2 citationsDouble modulation of 5-fluorouracil in the treatment of advanced colorectal carcinoma: Report of a trial with sequential methotrexate, intravenous (loading dose) folin...Edward P. Balaban, Mateel Graham, Steve Perkins, Richard G. Sheehan, Eugene P. Frenkel
Cancer Investigation. 1994-01-01 - 19 citationsA phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effectsRobert S. Witte, Brian T. Pruitt, Douglass C. Tormey, Scot E. Moss, David P. Rose
Cancer. 1986-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
